Sapacitabine
Sapacitabine (CS-682) is an orally bioavailable nucleoside analog prodrug investigated for acute myeloid leukemia (AML) . Preclinical in vitro and in vivo studies demonstrate its anti-tumor activity via DNA synthesis inhibition, supporting its role as a research compound for oncology and hematology.
Product Specifications
CAS Number
151823-14-2
Product Name Alternative
Sapacitabine, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Nucleoside Antimetabolite, Nucleoside Analogue, CS682, CS-682, CYC 682, CYC682, CYC-682, CS 682, Analog
Field of Research
Cell Biology, Molecular Biology
Purity
98.82% (May vary between batches)
Solubility
DMSO:20 mg/mL (40.76 mM)
Smiles
CCCCCCCCCCCCCCCC (=O) Nc1ccn ([C@@H]2O[C@H] (CO) [C@@H] (O) [C@@H]2C#N) c (=O) n1
Molecular Formula
C26H42N4O5
Molecular Weight
490.64
Storage Conditions
Store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6186172-01 0.1 mL
FXN (frataxin, CyaY, FA, FARR, FRDA, MGC57199, X25) (PE)
Sign In for Pricing
View Details